Prevention and therapy of tumors with arotinoids.
Sherman
M I
MI
Department of Oncology and Virology, Roche Research Center, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
Truitt
G A
GA
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D006801:Humans; D006986:Hypervitaminosis A / Q000139:chemically induced; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D012176:Retinoids / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001565:Benzoates; D012176:Retinoids; C038864:4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid; C053595:temarotene